UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ulva lactuca , A Source of Troubles and Potential Riches

Marine drugs, 2019-06, Vol.17 (6), p.357

2019

Volltextzugriff (PDF)

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Retrovirology, 2009-05, Vol.6 (50), p.50-50, Article 50

2009

Volltextzugriff (PDF)

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

Infectious disorders drug targets, 2012-02, Vol.12 (1), p.81-86

2012

Volltextzugriff (PDF)

A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity

Marine drugs, 2018-04, Vol.16 (4), p.134

2018

Volltextzugriff (PDF)

HIV-1 Clade B Tat, but Not Clade C Tat, Increases X4 HIV-1 Entry into Resting but Not Activated CD4+ T Cells

The Journal of biological chemistry, 2010-01, Vol.285 (3), p.1681-1691

2010

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from Monocytes

Journal of Virology, 2007-06, Vol.81 (11), p.5919-5928

2007

Volltextzugriff (PDF)

The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

The Journal of biological chemistry, 2004-11, Vol.279 (46), p.48197-48204

2004

Volltextzugriff (PDF)

The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells

The Journal of biological chemistry, 2005-11, Vol.280 (46), p.38376-38382

2005

Volltextzugriff (PDF)

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

Retrovirology, 2016-04, Vol.13 (21), p.21-21, Article 21

2016

Volltextzugriff (PDF)

Identification of a Highly Conserved Surface on Tat Variants

The Journal of biological chemistry, 2013-06, Vol.288 (26), p.19072-19080

2013

Volltextzugriff (PDF)

HIV-1 Tat protein enhances microtubule polymerization

Retrovirology, 2005-02, Vol.2 (1), p.5-5

2005

Volltextzugriff (PDF)

Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants

The Journal of biological chemistry, 2002-09, Vol.277 (39), p.35915-35919

2002

Volltextzugriff (PDF)

Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant

Retrovirology, 2008-09, Vol.5 (1), p.83-83, Article 83

2008

Volltextzugriff (PDF)

A Monoclonal Antibody Directed against a Conformational Epitope of the HIV-1 Trans-activator (Tat) Protein Neutralizes Cross-clade

The Journal of biological chemistry, 2012-04, Vol.287 (15), p.11942-11950

2012

Volltextzugriff (PDF)

Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine

Retrovirology, 2006-01, Vol.3 (1), p.8-8, Article 8

2006

Volltextzugriff (PDF)

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

Retrovirology, 2016-05, Vol.13 (1), p.35-35, Article 35

2016

Volltextzugriff (PDF)

Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins

AIDS research and human retroviruses, 2011-06, Vol.27 (6), p.647-654

2011

Volltextzugriff (PDF)

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

Vaccine, 2014-11, Vol.32 (48), p.6527-6536

2014

Volltextzugriff (PDF)

Structure-function relationships of the HIV-1 Tat protein

Retrovirology, 2009-09, Vol.6 (Suppl 2), p.P51-P51, Article P51

Loret, Erwann P

2009

Volltextzugriff (PDF)

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties

Vaccine, 2007-12, Vol.25 (50), p.8441-8447

2007

Volltextzugriff (PDF)

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

Journal of Virus Eradication, 2016-05, Vol.2, p.39-39

2016

Volltextzugriff (PDF)

An anti-insect toxin purified from the scorpion Androctonus australis Hector also acts on the .alpha.- and .beta.-sites of the mammalian sodium channel: sequence and circular dichroism study

Biochemistry (Easton), 1991-01, Vol.30 (3), p.633-640

1991

Volltextzugriff (PDF)

Full-length HIV-1 Tat protein necessary for a vaccine

Vaccine, 2004-08, Vol.22 (23), p.3105-3111

2004

Volltextzugriff (PDF)

Cutting Edge: HIV-1 Tat Protein Differentially Modulates the B Cell Response of Naive, Memory, and Germinal Center B Cells

The Journal of immunology (1950), 1999-08, Vol.163 (3), p.1119-1122

1999

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Englisch
(49)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(24)
Amino Acid Sequence
(20)
Molecular Sequence Data
(18)
Human Immunodeficiency Virus 1
(17)
Animals
(16)
Biochemistry & Molecular Biology
(16)
Virology
(16)
Circular Dichroism
(15)
Models, Molecular
(14)
Tat Gene Products, Human Immunodeficiency Virus
(13)
Biological And Medical Sciences
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Protein Conformation
(11)
Proteins
(11)
Gene Products, Tat - Chemistry
(9)
Hela Cells
(9)
Hiv
(9)
Hiv-1 - Immunology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulva lactuca , A Source of Troubles and Potential Riches

Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity

HIV-1 Clade B Tat, but Not Clade C Tat, Increases X4 HIV-1 Entry into Resting but Not Activated CD4+ T Cells

Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from Monocytes

The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

Identification of a Highly Conserved Surface on Tat Variants

HIV-1 Tat protein enhances microtubule polymerization

Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants

Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant

A Monoclonal Antibody Directed against a Conformational Epitope of the HIV-1 Trans-activator (Tat) Protein Neutralizes Cross-clade

Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine

Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial

Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

Structure-function relationships of the HIV-1 Tat protein

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

An anti-insect toxin purified from the scorpion Androctonus australis Hector also acts on the .alpha.- and .beta.-sites of the mammalian sodium channel: sequence and circular dichroism study

Full-length HIV-1 Tat protein necessary for a vaccine

Cutting Edge: HIV-1 Tat Protein Differentially Modulates the B Cell Response of Naive, Memory, and Germinal Center B Cells

Suchergebnisse filtern